In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
$470 million in funding will support new studies of large groups of people (called cohorts) and expand existing cohort studies to include a focus on Long COVID.
News Release
EHRObservationalTissue PathologyAdultPediatricPregnant Women